Jen Nwankwo ^UDM

Dr. Jen Nwankwo leads 1910 Genetics with a mission to integrate AI, computation, and biological automation in drug design. The company's unique drug discovery engines, ELVIS™ and ROSALYND™, position it at the forefront of AI-driven therapeutic design. Under Nwankwo's guidance, 1910 Genetics aims to enhance drug development timelines and success rates, bringing innovative treatments more efficiently to patients.